The Covid-19 pandemic exposed a serious flaw in the United States’ medical supply chain: an overreliance on imports, especially from China.
Reinvigorating our domestic supply chain protects the health of Americans and the country’s national security, which is why I reintroduced the bipartisan MADE in America Act.
The Manufacturing API, Drugs, and Excipients in America Act will prevent drug shortages and medical supply chain crunches while incentivizing the domestic manufacturing of drugs, PPE and diagnostics.
America’s scientific community is second to none so there’s no reason we shouldn’t also lead the world in making lifesaving medications. Bolstering American-made pharmaceutical production will support high-paying jobs and ensure that the country isn’t exposed to future supply chain breakdowns, whether due to a pandemic, war or some other unforeseen crisis.
Learn more about the bill here.